Drug Type Chemical drugs |
Synonyms- |
Mechanism Akt modulators(Proto-oncogene proteins c-akt modulators), HDAC2 inhibitors(Histone deacetylase 2 inhibitors), MYC modulators(Myc proto-oncogene protein modulators) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoid Leukemia | Preclinical | GB | 09 Dec 2022 |